{"id":4159,"date":"2024-01-13T19:25:15","date_gmt":"2024-01-13T19:25:15","guid":{"rendered":"https:\/\/clinics.law.harvard.edu\/hlep\/?page_id=4159"},"modified":"2024-03-05T16:07:28","modified_gmt":"2024-03-05T16:07:28","slug":"symposium-2024","status":"publish","type":"page","link":"https:\/\/clinics.law.harvard.edu\/hlep\/symposium-2024\/","title":{"rendered":"Symposium 2024"},"content":{"rendered":"<h4><b>&#8220;Why Can&#8217;t We Be Friends? <\/b><b>Innovators and Their Regulators&#8221;<\/b><\/h4>\n<p>How do we innovate within limits? How can we create with control? In a world where government oversight and regulation is an ever-looming foe, we seek to understand how entrepreneurs and start-ups can use this regulatory landscape not to curtail, but complement their ideas to maximize opportunities and growth.<\/p>\n<p>Our trilogy of speaker panels will discuss heavily regulated industries, including Sports Betting, Healthcare, and FinTech. Take a look below for the agenda, as well as info on the amazing speakers that will be joining us!<\/p>\n<h6><\/h6>\n<h6><span style=\"font-weight: 400\"><strong>Sports Betting \u2013 February 28th<\/strong> 12:15-1:15PM in WCC 1015<\/span><\/h6>\n<p><span style=\"font-weight: 400\">Joe Solosky, <em>Managing Director of Sports Betting at NASCAR<\/em><\/span><\/p>\n<p><span style=\"font-weight: 400\">Josh Jessen, <em>Chief Legal Officer of BetMGM<\/em><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4482\" src=\"http:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2-300x300.png 300w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2-1024x1024.png 1024w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2-150x150.png 150w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2-768x768.png 768w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/2.png 1080w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<h6><strong>Healthcare \u2013 February 28th <\/strong><span style=\"font-weight: 400\">3:30-4:30PM in WCC 1023<\/span><\/h6>\n<p><span style=\"font-weight: 400\">Erin Albert, <em>General Counsel of Mark Cuban\u2019s Cost Plus Drug Company&#8217;<\/em><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4483\" src=\"http:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3-300x300.png 300w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3-1024x1024.png 1024w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3-150x150.png 150w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3-768x768.png 768w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/3.png 1080w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<h6><span style=\"font-weight: 400\"><strong>FinTech \u2013 March 6th<\/strong> 12:15-1:15PM in WCC 1015<\/span><\/h6>\n<p><span style=\"font-weight: 400\">Daniel Gallagher, <em>Chief Legal Officer at RobinHood<\/em><\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4484\" src=\"http:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4-300x300.png\" alt=\"\" width=\"300\" height=\"300\" srcset=\"https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4-300x300.png 300w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4-1024x1024.png 1024w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4-150x150.png 150w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4-768x768.png 768w, https:\/\/clinics.law.harvard.edu\/hlep\/files\/2024\/02\/4.png 1080w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><a href=\"https:\/\/docs.google.com\/forms\/d\/e\/1FAIpQLSfuo8rey8LRJ2ish27pmTDgs3z5zlEUh4R0XSouYoIV5tI4Ww\/viewform?usp=sf_link\">RSVP here<\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Why Can&#8217;t We Be Friends? Innovators and Their Regulators&#8221; How do we innovate within limits? How can we create with control? In a world where government oversight and regulation is an ever-looming foe, we seek to understand how entrepreneurs and start-ups can use this regulatory landscape not to curtail, but complement their ideas to maximize [&hellip;]<\/p>\n","protected":false},"author":11926,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"class_list":{"0":"post-4159","1":"page","2":"type-page","3":"status-publish","5":"entry","6":"has-post-thumbnail"},"_links":{"self":[{"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/pages\/4159","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/users\/11926"}],"replies":[{"embeddable":true,"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/comments?post=4159"}],"version-history":[{"count":0,"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/pages\/4159\/revisions"}],"wp:attachment":[{"href":"https:\/\/clinics.law.harvard.edu\/hlep\/wp-json\/wp\/v2\/media?parent=4159"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}